Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2026-01-12 @ 7:46 AM
Study NCT ID:
NCT05528705
Status:
COMPLETED
Last Update Posted:
2024-05-31
First Post:
2022-09-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome
Sponsor:
Green Cross Wellbeing
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-01
First Submit QC Date:
None
Study First Post Date:
2022-09-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-30
Last Update Post Date:
2024-05-31
Last Update Post Date Type:
ACTUAL